DK1150667T3 - Langkædet cyclohexenonalkohol til behandling af amytrofisk lateralsklerose - Google Patents

Langkædet cyclohexenonalkohol til behandling af amytrofisk lateralsklerose

Info

Publication number
DK1150667T3
DK1150667T3 DK00902903T DK00902903T DK1150667T3 DK 1150667 T3 DK1150667 T3 DK 1150667T3 DK 00902903 T DK00902903 T DK 00902903T DK 00902903 T DK00902903 T DK 00902903T DK 1150667 T3 DK1150667 T3 DK 1150667T3
Authority
DK
Denmark
Prior art keywords
sup
lateral sclerosis
active ingredient
cyclohexenone
long
Prior art date
Application number
DK00902903T
Other languages
English (en)
Inventor
Bang Luu
Gaby Schmitt
Florence Keyling
Celine Girlanda-Junges
Philippe Chabert
Jean-Philippe Loeffler
Bernadette Lutz-Bucher
De Aguilar Jose-Luis Gonzalez
Masashi Yamada
Yukie Suma
Original Assignee
Meiji Dairies Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Dairies Corp filed Critical Meiji Dairies Corp
Application granted granted Critical
Publication of DK1150667T3 publication Critical patent/DK1150667T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C403/00—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone
    • C07C403/06—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by singly-bound oxygen atoms
    • C07C403/08—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by singly-bound oxygen atoms by hydroxy groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/51—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition
    • C07C45/511—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition involving transformation of singly bound oxygen functional groups to >C = O groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/56—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds
    • C07C45/57—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with oxygen as the only heteroatom
    • C07C45/59—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with oxygen as the only heteroatom in five-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/673—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by change of size of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/703—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
    • C07C49/713—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups a keto group being part of a six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK00902903T 1999-02-10 2000-02-10 Langkædet cyclohexenonalkohol til behandling af amytrofisk lateralsklerose DK1150667T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP3331299 1999-02-10
JP18054699A JP4469441B2 (ja) 1999-02-10 1999-06-25 神経変性疾患の予防又は治療薬

Publications (1)

Publication Number Publication Date
DK1150667T3 true DK1150667T3 (da) 2004-08-30

Family

ID=26371993

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00902903T DK1150667T3 (da) 1999-02-10 2000-02-10 Langkædet cyclohexenonalkohol til behandling af amytrofisk lateralsklerose

Country Status (10)

Country Link
US (1) US7166642B1 (da)
EP (1) EP1150667B1 (da)
JP (1) JP4469441B2 (da)
AT (1) ATE270884T1 (da)
CA (1) CA2360246C (da)
DE (1) DE60012143T2 (da)
DK (1) DK1150667T3 (da)
ES (1) ES2223456T3 (da)
PT (1) PT1150667E (da)
WO (1) WO2000047199A1 (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4861560B2 (ja) * 2001-02-19 2012-01-25 株式会社明治 糖尿病合併症治療剤
CA2447716A1 (en) * 2001-05-24 2002-11-28 Meiji Dairies Corporation Preventive or remedy for diseases caused by cerebrovascular disturbances
WO2003049666A2 (en) * 2001-12-13 2003-06-19 Firmenich Sa Compounds for a controlled release of active molecules
EP1608612B1 (en) * 2003-03-28 2008-02-27 Meiji Dairies Corporation Process for producing cyclohexenone long-chain alcohols
FR2860233B1 (fr) * 2003-09-26 2007-10-19 Univ Pasteur Composes promoteurs de la differenciation des precurseurs d'oligodendrocytes et modulateurs de l'activation microgliale, compositions et utilisations.
JP4827739B2 (ja) * 2004-10-13 2011-11-30 株式会社明治 ＳＴＡＴ３リン酸化抑制及びＮｏｔｃｈ１発現抑制剤
CN101065119B (zh) * 2004-11-25 2010-08-25 明治乳业株式会社 肾功能不全的改良剂
CN101180041B (zh) * 2005-01-18 2011-04-13 明治乳业株式会社 感觉障碍治疗剂
CA2609595C (en) * 2005-05-26 2013-01-08 Meiji Dairies Corporation Preventive and/or therapeutic agents for diabetic vascular disorders and respiratory disorders
WO2014081675A1 (en) * 2012-11-21 2014-05-30 Golden Biotechnology Corporation Methods and compositions for treating neurodegenerative diseases
CA3011913C (en) * 2016-01-22 2023-02-14 Taiho Pharmaceutical Co., Ltd. Manufacturing method for high-purity cyclohexenone long-chain alcohol
CN110187044B (zh) * 2019-01-17 2021-04-27 山东省农业科学院家禽研究所 一种银翘解毒口服液的质量检测方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69026496D1 (de) * 1989-10-13 1996-05-15 Neurofit Analoge von vitamin a und ihre verwendung, insbesondere als cytotrophische und cytoprotective substanzen sowie diese substanzen enthaltende arzneimittel
ATE105282T1 (de) 1992-11-18 1994-05-15 Medafor Langkettige fettalkohole mit neurotropischer und gedaechtnissfoerdernder wirkung.
US5843641A (en) 1993-02-26 1998-12-01 Massachusetts Institute Of Technology Methods for the daignosis, of familial amyotrophic lateral sclerosis
US5786391A (en) 1995-01-11 1998-07-28 Cornell Research Foundation, Inc. Regulating gene expression using retinoids with Ch2 OH or related groups at the side chain terminal position
US5731354A (en) * 1996-05-06 1998-03-24 Clarion Pharmaceuticals Inc. Treatment for the inhibition of neuro-degenerative disease states
JP3766591B2 (ja) 1997-08-13 2006-04-12 明治乳業株式会社 シクロヘキセノン長鎖アルコール及びこれを含有する医薬

Also Published As

Publication number Publication date
JP2000297034A (ja) 2000-10-24
ATE270884T1 (de) 2004-07-15
US7166642B1 (en) 2007-01-23
CA2360246C (en) 2008-04-15
ES2223456T3 (es) 2005-03-01
DE60012143T2 (de) 2004-11-25
EP1150667B1 (en) 2004-07-14
PT1150667E (pt) 2004-09-30
WO2000047199A1 (en) 2000-08-17
CA2360246A1 (en) 2000-08-17
EP1150667A1 (en) 2001-11-07
DE60012143D1 (de) 2004-08-19
JP4469441B2 (ja) 2010-05-26

Similar Documents

Publication Publication Date Title
TNSN05104A1 (fr) Derives de thiazole pour le traitement de troubles neurodegeneratifs
DE69811905T2 (de) Cyclohexenon langketten alkohol und diese enthaltendes arzneimittel
DK1150667T3 (da) Langkædet cyclohexenonalkohol til behandling af amytrofisk lateralsklerose
EP0849256A4 (en) AMIDE COMPOUNDS AND THEIR USE
MY141661A (en) 17b-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
DE60329316D1 (de) Phenylcarboxamide als beta-sekretase-hemmer zur behandlung von alzheimer
HUP0400732A2 (hu) Gyógyászatilag hatékony uridin-észterek
HUP0002960A2 (hu) Aril-oxi-szulfonil-amino-hidroxámsav-származékok
MA25809A1 (fr) Derives d'arylmethylamine pour usage comme inhibiteurs de tryptase
MA26956A1 (fr) Pyrimidine-2,4,6,triones inhibitrices de metalloproteinases.
HUP0203300A2 (hu) Immunoszuppresszáns 2,4-diamino-pirimidin vegyületek, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
WO2002089782A3 (en) Dioxanes and uses thereof
NO20025510D0 (no) Tienodibenzoazulenforbindelser som tumor nekrose faktor inhibitorer
MXPA04003611A (es) Piperidina- y piperazinacetaminas como inhibidores de la 17 beta-hidroxiesteroide deshidrogenasa tipo 3 para el tratamiento de enfermedades androgeno-dependientes.
HUP0101963A2 (hu) Interleukin-1béta átalakító enzim szukcinamid inhibitorai
DE60216239T8 (de) Verwendung von Cyclohexenon-Derivaten zur Herstellung eines Arzneimittels zur Behandlung von Dysurie
DE60139409D1 (de) Pharmazeutische zusammensetzungen die ein dibenzocyclooctanlignanderivat enthalten zur vorbeugung und behandlung neurodegenerativer erkrankungen
EP1201240A3 (en) Heterocyclic derivatives useful as pharmaceutical agents
DK0832078T3 (da) N-hydroxyurinstoffer som anti-inflammatoriske midler
DE60238666D1 (de) Cyclohexenon derivate zur behandlung der diabetischen neuropathie
ATE294780T1 (de) Arylpiperidin- und aryl-1,2,5,6- tetrahydropyridinamid-derivate mit 5ht1a rezeptor aktivität
WO2000027378A3 (en) Cystine derivatives as therapeutic agents for matrix metalloprotease related diseases
CA2348319A1 (en) Cyclohexenol derivative and medicament containing the same
AU4544096A (en) New derivatives of glycylanilides, preparation and therapeutical application